HGP Advises symplr in Acquisition of GreenLight Medical

March 10, 2022

symplr, the leader in enterprise healthcare operations, backed by Clearlake Capital Group, L.P. and Charlesbank Capital Partners, announced that it has entered into an agreement to purchase GreenLight Medical, a provider of healthcare supply chain management software. 

“GreenLight Medical is a natural complement to our healthcare operations portfolio. The combination of symplr’s Spend Management offering and GreenLight’s software platform will enable financial leaders across health systems to make more informed spending decisions,” said BJ Schaknowski, CEO of symplr. “Healthcare systems today are seeking integrated and connected enterprise solutions. Our vision for symplr Spend Management is to deliver streamlined supply chain decision support, making it easier for leaders to make informed, timely, value-based, and defensible purchase decisions.” 

GreenLight Medical’s cloud-based software platform is the first solution that provides healthcare organizations with quality and value-based data for evaluating, purchasing, and deploying new medical technology, streamlining collaborative and compliant purchasing decisions. Together, symplr and GreenLight Medical will offer one of the industry’s most comprehensive spend management and value analysis SaaS solutions, enhanced by symplr’s robust data warehouse with over 20 years of capital market intelligence and symplr’s Hayes clinical evidence software solution. By connecting these solutions into one comprehensive view, the consolidated symplr platform will dramatically improve spend management, as well as critical financial and clinical outcomes. 

To read more, visit the press release here.

Recent Research & News

Healthcare Market Matrix Podcast – Navigating a Health IT Market in Flux: Key Insights as We Head Into Q4

Defining the ‘New Normal’ in Private Equity: Findings from HGP and Eliciting Insights’ 2024 PE Survey

HGP Observations – September 2024